HealthTree Podcast for Multiple Myeloma artwork

HealthTree Podcast for Multiple Myeloma

210 episodes - English - Latest episode: 6 months ago - ★★★★★ - 13 ratings

HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.

Health & Fitness myeloma multiple myeloma
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

mPatient Myeloma Radio: Dr. Robert A. Kyle, Mayo Clinic

August 09, 2013 20:00 - 1 hour - 16.2 MB

This week on mPatient Myeloma Radio, listen to Dr. Robert A. Kyle, a pioneer in myeloma research, as he gives us perspective on the history of "Innovation in Myeloma" and his lengthy research as the first to identify MGUS and smoldering myeloma. 

HealthTree Podcast for Multiple Myeloma: Dr. Robert A. Kyle, Mayo Clinic

August 09, 2013 20:00 - 1 hour - 16.2 MB

This week on HealthTree Podcast for Multiple Myeloma, listen to Dr. Robert A. Kyle, a pioneer in myeloma research, as he gives us perspective on the history of "Innovation in Myeloma" and his lengthy research as the first to identify MGUS and smoldering myeloma. 

HealthTree Podcast for Multiple Myeloma: Dr. C. Ola Landgren, NCI

August 02, 2013 18:00 - 1 hour - 14.4 MB

This week on HealthTree Podcast for Multiple Myeloma, listen to Dr. Landgren as we discuss his research in new therapies for myeloma in its precursor states (MGUS and smoldering), molecular profiling of myeloma and why it is important in predicting progression, and his related research with myeloma and the immune system. 

mPatient Myeloma Radio: Dr. C. Ola Landgren, NCI

August 02, 2013 18:00 - 1 hour - 14.4 MB

This week on mPatient Myeloma Radio, listen to Dr. Landgren as we discuss his research in new therapies for myeloma in its precursor states (MGUS and smoldering), molecular profiling of myeloma and why it is important in predicting progression, and his related research with myeloma and the immune system. 

mPatient Myeloma Radio: Dr. Don Benson, The James Ohio State

July 19, 2013 20:00 - 1 hour - 23.8 MB

This week on mPatient Myeloma Radio, listen to the first in a two-part series with Dr. Benson as he gives us a primer in clinical trials. Because only 5% of myeloma patients participate in clinical trials, we want you to know all about them so you can understand why you would want to enroll, how they are staged, who funds them and what you can expect in outcomes.

HealthTree Podcast for Multiple Myeloma: Dr. Don Benson, The James Ohio State

July 19, 2013 20:00 - 1 hour - 23.8 MB

This week on HealthTree Podcast for Multiple Myeloma, listen to the first in a two-part series with Dr. Benson as he gives us a primer in clinical trials. Because only 5% of myeloma patients participate in clinical trials, we want you to know all about them so you can understand why you would want to enroll, how they are staged, who funds them and what you can expect in outcomes.

HealthTree Podcast for Multiple Myeloma: Dr. Guido Tricot, University of Iowa

July 12, 2013 22:00 - 52 minutes - 11.8 MB

  This week on HealthTree Podcast for Multiple Myeloma listen to Dr. Guido Tricot discuss his latest research and open clinical trials.  

mPatient Myeloma Radio: Dr. Guido Tricot, University of Iowa

July 12, 2013 22:00 - 52 minutes - 11.8 MB

This week on mPatient Myeloma Radio, listen to Dr. Guido Tricot discuss his latest research and open clinical trials.

mPatient Myeloma Radio: Dr. Robert Z. Orlowski, MD Anderson

July 05, 2013 21:00 - 34 minutes - 7.78 MB

This week on mPatient Myeloma Radio, listen to myeloma pioneer Dr. Robert Z. Orlowski discuss his latest research and open clinical trials in our first patient internet radio interview.

HealthTree Podcast for Multiple Myeloma: Dr. Robert Z. Orlowski, MD Anderson

July 05, 2013 21:00 - 34 minutes - 7.78 MB

This week on HealthTree Podcast for Multiple Myeloma, listen to myeloma pioneer Dr. Robert Z. Orlowski discuss his latest research and open clinical trials in our first patient internet radio interview.